| Laura L Feldman, DO | |
|
630 Southpointe Ct, Suite 104, Colorado Springs, CO 80906-3896 | |
| (719) 955-9060 | |
| (719) 955-2854 |
| Full Name | Laura L Feldman |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 630 Southpointe Ct, Colorado Springs, Colorado |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003842717 | NPI | - | NPPES |
| 01260405 | Medicaid | CO | |
| 26040 | Other | CO | STATE LICENSE |
| 26102846 | Medicaid | CO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 26040 (Colorado) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Laura L Feldman, DO 630 Southpointe Ct, Suite 104, Colorado Springs, CO 80906-3896 Ph: (719) 955-9060 | Laura L Feldman, DO 630 Southpointe Ct, Suite 104, Colorado Springs, CO 80906-3896 Ph: (719) 955-9060 |
News Archive
A University of Alberta-led research team has taken a major step forward in understanding how T cells are activated in the course of an immune response by combining nanotechnology and cell biology. T cells are the all important trigger that starts the human body's response to infection.
CASI Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a commercial focus on China, announced today that the China Food and Drug Administration (CFDA) has approved the Company's application to conduct a Phase 2 global clinical trial in ovarian clear cell carcinoma (OCCC) patients for its proprietary drug candidate ENMD-2076.
Santarus, Inc., a specialty biopharmaceutical company, today announced the publication of an integrated analysis of two randomized placebo-controlled clinical trials with RHUCIN (recombinant human C1 inhibitor, or rhC1INH), in the October issue of the peer reviewed Journal of Allergy and Clinical Immunology (JACI).
A new study published in the Journal of Trauma and Acute Care Surgery finds that diaphragm pacing (DP) stimulation in spinal cord-injured patients is successful not only in weaning patients from mechanical ventilators but also in bridging patients to independent respiration, where they could breathe on their own without the aid of a ventilator or stimulation.
› Verified 4 days ago
Dr. Ronald S.b. Doria, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1650 Cochrane Cir, Colorado Springs, CO 80913 Phone: 719-526-2361 | |
Jamieson D Kennedy, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2020 W Colorado Ave, Ste 203, Colorado Springs, CO 80904 Phone: 719-473-2368 Fax: 719-473-4581 | |
Dr. Dorothy L Saune, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3027 N Circle Dr, Colorado Springs, CO 80909 Phone: 719-776-4646 Fax: 719-776-4640 | |
Dr. Paolo Juan Bahr, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4105 Briargate Pkwy Ste 125, Colorado Springs, CO 80920 Phone: 303-338-4545 | |
Georgette Chekiri, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 9320 Grand Cordera Pkwy Ste 100, Colorado Springs, CO 80924 Phone: 719-282-6337 Fax: 719-282-0532 | |
Dr. Max A Nevarez, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 6340 Barnes Rd, Colorado Springs, CO 80922 Phone: 719-522-1133 Fax: 719-570-0602 |